Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Journal of Cancer - Australia
doi 10.7150/jca.20889
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2017
Authors
Publisher
Ivyspring International Publisher